Table S3.
Patient sample | Primary tumor location | pTNM | Observations | RELAPSE |
P1 | Right colon | T1N0 | Conventional | — |
P2 | Left colon | T3N2 | FO adjuvant | Yes |
P3 | Right colon | T3N2a | Mucinous | — |
P4 | Right colon | T3N1b | Mucinous | — |
P5 | Right colon | T3N1a | Conventional | — |
P7 | Left colon | pT4N0 | FO adjuvant | No |
P8 | Right colon | pT4N0 | Neoadjuvant FOLFOXIRI + FOLFOX adjuvant | No |
P9 | Rectum | pT3N1c | FO adjuvant | No |
P10 | Right colon | pT3N2a | FO adjuvant | Yes |
P11 | Rectum | pT1N0 | No treatment | — |
List of surgically resected human CRC tumors samples. Tumor node metastasis status: T1, tumor invades submucosa; T3, growth into the outermost layers of the colon. pN0, no malignant lymph nodes; pN1, cancer cells are found in one to three lymph nodes; pN1a, cancer cells in one regional lymph node; pN1b, cancer cells in two to three regional lymph nodes; pN2, cancer cells in four or more regional lymph nodes; pN2a, cancer cells are found in four to six lymph nodes. Relapse after 3 mo to 6 mo postsurgery.